Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

ST6GalNAc-I, the sialyltransferase responsible for sialyl-Tn (sTn) synthesis, has been previously reported to be positively associated with cancer aggressiveness. Here we describe a novel sTn-dependent mechanism for chemotherapeutic resistance. We show that sTn protects cancer cells against chemotherapeutic-induced cell death by decreasing the interaction of cell surface glycan receptors with galectin-3 and increasing its intracellular accumulation. Moreover, exogenously added galectin-3 potentiated the chemotherapeutics-induced cytotoxicity in sTn non-expressing cells, while sTn overexpressing cells were protected. We also found that the expression of sTn was associated with a reduction in galectin-3-binding sites in human gastric samples tumors. ST6GalNAc-I knockdown restored galectin-3-binding sites on the cell surface and chemotherapeutics sensibility. Our results clearly demonstrate that an interruption of O-glycans extension caused by ST6GalNAc-I enzymatic activity leads to tumor cells resistance to chemotherapeutic drugs, highlighting the need for the development of novel strategies to target galectin-3 and/or ST6GalNAc-I.

Original publication

DOI

10.18632/oncotarget.13192

Type

Journal article

Journal

Oncotarget

Publication Date

13/12/2016

Volume

7

Pages

83570 - 83587

Keywords

chemotherapy resistance, galectin-3, gastric cancer, glycosylation, sialyl-Tn, Animals, Antigens, Tumor-Associated, Carbohydrate, Antineoplastic Agents, Cell Line, Tumor, Cell Proliferation, Cisplatin, Dose-Response Relationship, Drug, Drug Resistance, Neoplasm, Galectin 3, Glycosylation, Humans, Mice, Inbred BALB C, Mice, Nude, Protein Processing, Post-Translational, Protein Transport, RNA Interference, Sialyltransferases, Stomach Neoplasms, Time Factors, Transfection, Tumor Burden